Arthritis News and Research

Latest Arthritis News and Research

Discovery may help cancer patients to avoid chemotherapy's debilitating side effects

A discovery by University of Queensland pain researchers may allow some future cancer patients, including children with leukemia, to avoid their chemotherapy's worst and most debilitating side effects.

15 Mar 2021

University of Missouri settles lawsuits over knee surgeries involving veterinarian

The University of Missouri has settled a collection of personal injury and false advertising claims over knee surgeries for $16.2 million, in what appears to be one of its largest public payouts in recent years.

12 Mar 2021

Dry eye disease negatively affects patients' health and vision related quality of life

Patients suffering from dry eye disease symptoms have a lower quality of life compared to those without symptoms, a new study reports.

11 Mar 2021

NTU scientists design new compound that could help reduce overactive immune response

When the body detects a pathogen, such as bacteria or viruses, it mounts an immune system response to fight this invader. In some people, the immune system overreacts, resulting in an overactive immune response that causes the body to injure itself, which may prove fatal in some cases.

10 Mar 2021

Tiny antibodies naturally generated by llamas can be effective against COVID-19

As the fight against COVID-19 continues, scientists have turned to an unlikely source for a potentially effective treatment: tiny antibodies naturally generated by llamas.

10 Mar 2021

New compound can reduce overactivation without impairing the body's immunity response

10 Mar 2021

Both ventral and dorsal surgeries improve outcomes in patients with cervical spondylotic myelopathy

Affecting the vast majority of people older than 65, cervical spondylotic myelopathy (CSM) is the leading cause of spinal cord dysfunction in the United States and across the world.

10 Mar 2021

Rheumatoid arthritis drug improves outcomes in severely ill COVID-19 patients, finds new trial

Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India -- one of the world's most ethnically diverse countries.

8 Mar 2021

Five-day course of high-dose antibiotic will do just as well for children with pneumonia

Many parents know the struggle of having to make children with pneumonia finish the usual 10-day course in antibiotics despite the child feeling better after a few days of medication.

8 Mar 2021

IQWiG's new threshold proven feasible in practice for early benefit assessments of drugs

Current examples prove the feasibility of the 15 percent threshold newly defined by IQWiG for the acceptance of responder analyses in early benefit assessments of drugs.

5 Mar 2021

AI-based method for repurposing existing drugs into potential treatments for Alzheimer's

New treatments for Alzheimer's disease are desperately needed, but numerous clinical trials of investigational drugs have failed to generate promising options.

4 Mar 2021

Scientists reprogram a common bacterium to make designer sugar-based drug

Envisioning an animal-free drug supply, scientists have - for the first time - reprogrammed a common bacterium to make a designer polysaccharide molecule used in pharmaceuticals and nutraceuticals.

2 Mar 2021

New 4D hydrogels may help develop tissues that closely resemble their natural counterparts

Tissue engineering has long-depended on geometrically static scaffolds seeded with cells in the lab to create new tissues and even organs.

2 Mar 2021

Study: Repurposed arthritis drug did not improve outcomes of patients with severe COVID-19 pneumonia

In a study published online February 25, 2021 in The New England Journal of Medicine, a repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia.

1 Mar 2021

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center employs new antibodies against genetically altered proteins to target cancers.

1 Mar 2021

New approach harnesses disease-causing proteins to combat cancer

Over many decades now, traditional drug discovery methods have steadily improved at keeping diseases at bay and cancer in remission. And for the most part, it's worked well.

26 Feb 2021

New hydrogel-based materials show promise for tissue engineering

New hydrogel-based materials that can change shape in response to psychological stimuli, such as water, could be the next generation of materials used to bioengineer tissues and organs, according to a team of researchers at the University of Illinois Chicago.

25 Feb 2021

Researchers discover specific blood biomarker that predicts kidney transplant rejection

Researchers at the University of Pittsburgh School of Medicine have discovered a blood biomarker that predicts kidney transplant rejection with a lead time of about eight months, which could give doctors an opportunity to intervene and prevent permanent damage.

25 Feb 2021

Research shows the effectiveness of a digital healthcare treatment for osteoarthritis

The steadily increasing prevalence and high costs of treating chronic joint pain worldwide poses a challenge for healthcare systems and healthcare payers.

24 Feb 2021

Tumors use unique mechanism to switch on regulatory T cells for protection

Immunologists at St. Jude Children's Research Hospital have discovered that tumors use a unique mechanism to switch on regulatory T cells to protect themselves from attack by the immune system.

24 Feb 2021

Arthritis News and Research

Latest Arthritis News and Research

Discovery may help cancer patients to avoid chemotherapy's debilitating side effects

University of Missouri settles lawsuits over knee surgeries involving veterinarian

Dry eye disease negatively affects patients' health and vision related quality of life

NTU scientists design new compound that could help reduce overactive immune response

Tiny antibodies naturally generated by llamas can be effective against COVID-19

New compound can reduce overactivation without impairing the body's immunity response

Both ventral and dorsal surgeries improve outcomes in patients with cervical spondylotic myelopathy

Rheumatoid arthritis drug improves outcomes in severely ill COVID-19 patients, finds new trial

Five-day course of high-dose antibiotic will do just as well for children with pneumonia

IQWiG's new threshold proven feasible in practice for early benefit assessments of drugs

AI-based method for repurposing existing drugs into potential treatments for Alzheimer's

Scientists reprogram a common bacterium to make designer sugar-based drug

New 4D hydrogels may help develop tissues that closely resemble their natural counterparts

Study: Repurposed arthritis drug did not improve outcomes of patients with severe COVID-19 pneumonia

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

New approach harnesses disease-causing proteins to combat cancer

New hydrogel-based materials show promise for tissue engineering

Researchers discover specific blood biomarker that predicts kidney transplant rejection

Research shows the effectiveness of a digital healthcare treatment for osteoarthritis

Tumors use unique mechanism to switch on regulatory T cells for protection

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Arthritis News and Research

Latest Arthritis News and Research

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in